Skip to search.
 NZX 50 Down 0.34%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
11.45 Down 0.83(6.76%) 18 Apr 08:00
|After Hours : 11.50 Up 0.05 (0.40%) 18 Apr 08:01
Add to Portfolio
Prev Close:12.28
Open:12.09
Bid:11.45 x 500
Ask:11.99 x 1000
1y Target Est:23.55
Beta:5.64
Earnings Date:6 May - 11 May (Est.)
Day's Range:11.41 - 12.09
52wk Range:10.85 - 18.48
Volume:2,731,055
Avg Vol (3m):1,721,000
Market Cap:1.19b
P/E (ttm):N/A
EPS (ttm):-1.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXDown 6.76%1.19b
BAXDown 0.34%37.93b
SHPGUp 0.10%47.81b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):117.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.95
Quarterly EPS Est (Mar-15) :-0.30
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback